Skip to content

Mannkind MNKD Restricted Cash

Restricted Cash at other companies

LQD
Liquidia CorporationLQDA
$3.5M
Lexicon Pharmaceuticals logo
Lexicon PharmaceuticalsLXRX
$29M
Mineralys Therapeutics, Inc. logo
Mineralys Therapeutics, Inc.MLYS
$0
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
$601K+29.5%
Boston Scientific logo
Boston ScientificBSX

Other financials

Income statement

See full
Revenue$90.2M+15.1%
Gross profit$82.7M+10.8%
Operating income-$1.7M-107%
Net income-$16.6M-226%
EPS (diluted)-$0.05-225%

Balance sheet

See full
Cash & equivalents$52.8M+11.7%
Total debt$12.2M-9.4%
Total equity-$59.2M-1.0%
Total assets$744.4M+81.5%

Cash flow

See full
Operating cash flow-$5.4M+15.9%
CapEx$1.9M+470%
Free cash flow-$7.2M-8.0%

Valuation

See full
Market cap$1.19B+3.5%
Enterprise value$1.15B+3.0%
P/E228.5×
P/S3.3×-0.6×

Profitability

See full
Gross margin91.5%-2.6pp
Operating margin23.3%+3.1pp
Net margin9.3%
FCF margin13.8%

Returns & leverage

See full
Return on equity-8.8%
Debt / equity-0.2×
Current ratio1.9×-0.5×

Where this comes from

Reported directly by Mannkind in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCash.

The official record: Mannkind’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mannkind's restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mannkind's restricted cash?
Mannkind (MNKD) reported restricted cash of $747K in Q1 2026.
How has Mannkind's restricted cash changed year-over-year?
Mannkind's restricted cash increased by 1.1% year-over-year, from $739K to $747K.
What is the long-term trend for Mannkind's restricted cash?
Over 2 years (2020 to 2025), Mannkind's restricted cash has grown at a 117.1% compound annual growth rate (CAGR), from $158K to $745K.
What does restricted cash mean?
Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.